US Food and Drug Administration Approves Prior Approval Supplement for Commercial Launch of Portola ...
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (NASDAQ:PTLA) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Prior Approval Supplement (PAS) for Bevyxxa ...